These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 15168453

  • 1. [Molecular biology of lung cancer].
    Akita H.
    Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):378-86. PubMed ID: 15168453
    [No Abstract] [Full Text] [Related]

  • 2. [Molecular abnormalities in lung cancer].
    Shimizu S, Mitsudomi T.
    Nihon Rinsho; 2002 May; 60 Suppl 5():73-7. PubMed ID: 12101773
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The molecular genetics of lung cancer.
    Carbone DP, Minna JD.
    Adv Intern Med; 1992 May; 37():153-71. PubMed ID: 1348393
    [No Abstract] [Full Text] [Related]

  • 5. Tumor suppressor genes in rodent lung carcinogenesis-mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis.
    Miller MS.
    Toxicol Appl Pharmacol; 1999 Apr 01; 156(1):70-7. PubMed ID: 10101101
    [No Abstract] [Full Text] [Related]

  • 6. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene.
    Qin G, Meng Z.
    Inhal Toxicol; 2010 Mar 01; 22(4):322-9. PubMed ID: 20064080
    [Abstract] [Full Text] [Related]

  • 7. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T, Takahashi T.
    Gan To Kagaku Ryoho; 1996 Jul 01; 23(8):990-6. PubMed ID: 8687234
    [Abstract] [Full Text] [Related]

  • 8. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM, Molina T, Theobald S, Depierre A, Lagrange JL, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A, FNCLCC, CRLCC.
    Bull Cancer; 2002 Oct 01; 89(10):857-67. PubMed ID: 12441277
    [Abstract] [Full Text] [Related]

  • 9. [Recent advances in gene change of pancreatic cancer].
    Wang YY, Cui QC.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb 01; 26(1):79-82. PubMed ID: 15052782
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetics of bladder cancer: pathways of development and progression.
    Knowles MA.
    Cancer Surv; 1998 Feb 01; 31():49-76. PubMed ID: 15281317
    [No Abstract] [Full Text] [Related]

  • 11. Molecular genetics of small cell lung carcinoma.
    Wistuba II, Gazdar AF, Minna JD.
    Semin Oncol; 2001 Apr 01; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [Abstract] [Full Text] [Related]

  • 12. [Abnormalities of molecular biology in premalignant lung lesions].
    Shao SJ, Wang Y, Yang PM.
    Ai Zheng; 2004 Jan 01; 23(1):99-103. PubMed ID: 14720385
    [Abstract] [Full Text] [Related]

  • 13. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M, Mukeria A, Le Calvez F, Hung RJ, Renard H, Cortot A, Bollart C, Zaridze D, Brennan P, Boffetta P, Brambilla E, Hainaut P.
    Cancer Res; 2007 Jun 15; 67(12):5667-72. PubMed ID: 17575133
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P, Zaravinos A, Zioga M, Spandidos DA.
    Br J Dermatol; 2009 Jun 15; 160(6):1215-21. PubMed ID: 19298278
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oncogenes and antioncogenes in human breast carcinoma.
    Leslie KO, Howard P.
    Pathol Annu; 1992 Jun 15; 27 Pt 1():321-42. PubMed ID: 1346552
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC.
    Oncogene; 1998 Nov 26; 17(21):2779-85. PubMed ID: 9840942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.